Livingston Group Asset Management Southport Capital Management Lifted Blackrock LTD Duration Tr Com Shs (BLW) Holding By $334,620; Biolase (BIOL) Sentiment Is 1.31

March 31, 2018 - By Marguerite Chambers

BIOLASE, Inc. (NASDAQ:BIOL) Logo

Biolase Inc (BIOL) investors sentiment increased to 1.31 in Q4 2017. It’s up 0.52, from 0.79 in 2017Q3. The ratio has improved, as 17 investment professionals increased or opened new stock positions, while 13 sold and reduced stock positions in Biolase Inc. The investment professionals in our database now possess: 36.99 million shares, up from 29.45 million shares in 2017Q3. Also, the number of investment professionals holding Biolase Inc in top ten stock positions was flat from 1 to 1 for the same number . Sold All: 7 Reduced: 6 Increased: 11 New Position: 6.

Livingston Group Asset Management Southport Capital Management increased Blackrock Ltd Duration Inc Tr Com Shs (BLW) stake by 29.07% reported in 2017Q4 SEC filing. Livingston Group Asset Management Southport Capital Management acquired 22,308 shares as Blackrock Ltd Duration Inc Tr Com Shs (BLW)’s stock declined 5.30%. The Livingston Group Asset Management Southport Capital Management holds 99,054 shares with $1.57M value, up from 76,746 last quarter. Blackrock Ltd Duration Inc Tr Com Shs now has $558.02M valuation. The stock increased 0.40% or $0.06 during the last trading session, reaching $15.08. About 119,585 shares traded or 20.78% up from the average. BlackRock Limited Duration Income Trust (NYSE:BLW) has declined 2.40% since March 31, 2017 and is downtrending. It has underperformed by 13.95% the S&P500.

Livingston Group Asset Management Southport Capital Management decreased Home Depot Inc Com (NYSE:HD) stake by 3,997 shares to 35,185 valued at $6.67 million in 2017Q4. It also reduced Abbvie Inc Com (Call) (NYSE:ABBV) stake by 12,496 shares and now owns 500 shares. Proshares Ultrashort 20 Year Treasury (TBT) was reduced too.

Investors sentiment decreased to 0.91 in 2017 Q4. Its down 0.01, from 0.92 in 2017Q3. It is negative, as 8 investors sold BLW shares while 15 reduced holdings. 5 funds opened positions while 16 raised stakes. 6.69 million shares or 0.47% less from 6.72 million shares in 2017Q3 were reported. Us National Bank De has invested 0% in BlackRock Limited Duration Income Trust (NYSE:BLW). Rivernorth Mngmt Limited Liability reported 179,684 shares. Northwestern Mutual Wealth Company has invested 0.01% in BlackRock Limited Duration Income Trust (NYSE:BLW). Ameriprise Incorporated has 0% invested in BlackRock Limited Duration Income Trust (NYSE:BLW). Fiera Cap Corporation owns 13,298 shares for 0% of their portfolio. Hollencrest Cap Management has invested 0.02% in BlackRock Limited Duration Income Trust (NYSE:BLW). Wells Fargo Mn invested in 391,298 shares or 0% of the stock. 176,876 were reported by Raymond James Serv Advsr. Raymond James Tru Na has 10,348 shares. Moreover, North Star Investment has 0% invested in BlackRock Limited Duration Income Trust (NYSE:BLW). Hl Fincl Svcs Lc accumulated 26,100 shares. Carroll Fincl Associates Inc reported 0% stake. Sandy Spring National Bank & Trust stated it has 5,000 shares. Private Mngmt Grp reported 145,467 shares. Suntrust Banks holds 0% or 18,788 shares.

Oracle Investment Management Inc holds 2.61% of its portfolio in BIOLASE, Inc. for 30.87 million shares. Trellus Management Company Llc owns 577,354 shares or 0.34% of their US portfolio. Moreover, Birchview Capital Lp has 0.32% invested in the company for 1.29 million shares. The New York-based Teton Advisors Inc. has invested 0.02% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 1,964 shares.

The stock decreased 3.33% or $0.014 during the last trading session, reaching $0.406. About 77,519 shares traded. BIOLASE, Inc. (BIOL) has declined 67.19% since March 31, 2017 and is downtrending. It has underperformed by 78.74% the S&P500.

BIOLASE, Inc., a medical device company, develops, makes, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company has market cap of $41.55 million. The firm offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. It currently has negative earnings. The Company’s dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications.

BIOLASE, Inc. (NASDAQ:BIOL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marguerite Chambers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: